HI
ICCC icon

Harbour Investments’s ImmuCell ICCC Stock Holding History

Harbour Investments’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58K Hold
250
– – ﹤0.01% 3979
2025
Q4 		$1.54K Buy
+250
New +$1.47K ﹤0.01% 3367
2021
Q4 		– Sell
-250
Closed -$2K – 3124
2021
Q3 		$2K Hold
250
– – ﹤0.01% 3312
2021
Q2 		$2K Hold
250
– – ﹤0.01% 3385
2021
Q1 		$2K Buy
+250
New +$2.35K ﹤0.01% 3222

Other funds holding ICCC

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Harbour Investments's ICCC Position: Q1 2026 in Review

Harbour Investments held its ImmuCell (ICCC) position steady in Q1 2026 at 250 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #3979.

Harbour Investments first reported a position in ICCC in Q1 2021 and has held it in 5 quarters since. The position peaked at $2K in Q3 2021. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

  • Harbour Investments held 250 shares of ImmuCell worth $1.58K as of Q1 2026.
  • Harbour Investments left its ImmuCell share count unchanged in Q1 2026.
  • ImmuCell made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3979 holding.
  • Harbour Investments first reported a position in ImmuCell in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's ImmuCell position peaked at $2K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.